Daily FNArena News

Ahead of the Herd’s Rick Mills notes the race to secure lithium supply is on, with the world’s biggest battery producer, China, leading the way.

Peter Switzer of the Switzer Super Report ticks off the boxes of recent developments that are positive for Australian stocks.

Fisher & Paykel Healthcare requires a significant improvement in its OSA mask performance as well as high growth rates in new hospital applications to meet targets, brokers assess.

BlueScope Steel is confronting higher input costs and slumping prices for its steel products in the US and several brokers fear a downgrade to the earnings outlook is on the cards.

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

Michael Gable of Fairmont Equities suggests TechnologyOne is showing signs the decline may soon be over.

Marc Kennis of Pitt Street Research recently sat down with Ralph Schmitt, CEO of Sensera.

A glance through the latest expert views and predictions about commodities. Lithium; oil; titanium dioxide; copper; gold; and steel.

Global supply of iron ore has fallen over 2019 and China’s port stocks are dwindling. So, how high can prices go?

Ahead of the Herd’s Rick Mills puts the case for the US-China trade war being less about trade and more about technological supremacy.